Management of local skin reactions after the application of ingenol mebutate gel for the treatment of actinic keratosis: Four illustrative cases

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 2, 2016, Pages 320-321

  Longo, C ^a   Neri, L ^b   Argenziano, G ^a   Calvieri, S ^c   Calzavara Pinton, P G ^d   Cantisani, C ^c   Catricala C ^e   Peris, K ^f   Peserico, A ^g   Pimpinelli, N ^h   Pellacani, G ⁱ  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

^e SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^f FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EMOLLIENT AGENT; INGENOL MEBUTATE; 3-INGENYL ANGELATE; DITERPENE;

ACTINIC KERATOSIS; ADULT; AGED; CASE REPORT; CONSULTATION; DERMATOLOGIST; FEMALE; HUMAN; LETTER; LOCAL SKIN REACTION; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; TREATMENT RESPONSE; VERY ELDERLY; WOUND HEALING; CHEMICALLY INDUCED; DISEASE MANAGEMENT; ERYTHEMA; FOLLOW UP; KERATOSIS, ACTINIC; PATHOLOGY; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; DISEASE MANAGEMENT; DITERPENES; ERYTHEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATOSIS, ACTINIC; MALE; SKIN;

EID: 84961347620     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12714     Document Type: Letter

References (7)

1. Schmitt AR, Bordeaux JS,. Actinic neoplasia syndrome and an update on the epidemiology of basal cell carcinoma, squamous cell carcinoma, and actinic keratosis. Curr Dermatol Rep 2013; 2: 42-47.
2. Stockfleth E, Kerl H, Guideline Subcommittee of the European Dermatology Forum. Guidelines for the management of actinic keratosis. Eur J Dermatol 2006; 16: 599-606.
3. Werner RN, Sammain A, Erdmann R, Hartmann V, Stockfleth E, Nast A,. The natural history of actinic keratosis: a systematic review. Br J Dermatol 2013; 169: 502-518. doi: 10.1111/bjd.12420.
4. Peserico A, Neri L, Calzavara Pinton P, et al,. Key opinion leader (KOL) consensus for actinic keratosis management in Italy: the AKTUAL Workshop. G Ital Dermatol Venereol 2013; 148: 515-524.
5. Cantisani C, De Gado F, Ulrich M, et al,. Actinic keratosis: review of the literature and new patents. Recent Pat Inflamm Allergy Drug Discov 2013; 7: 168-175.
6. Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B,. Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012; 366: 1010-1019.
7. Horne R, Chapman SC, Parham R, et al,. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS ONE 2013; 8: e80633.